Zentalis Pharmaceuticals (ZNTL) Tax Provisions (2019 - 2026)

Zentalis Pharmaceuticals (ZNTL) posted quarterly Tax Provisions of $120000.0 for Q1 2026, down 72.85% quarter-over-quarter from $442000.0 in Q4 2025.

Zentalis Pharmaceuticals (ZNTL) Tax Provisions (2019 - 2026) Analysis & Trends

Zentalis Pharmaceuticals' Tax Provisions history runs 8 years deep, the most recent figure standing at $120000.0 for Q1 2026.

In Q1 2026, Tax Provisions changed N/A year-over-year to $120000.0; the TTM figure through Mar 2026 stood at $562000.0 (up 1552.94% YoY), while the FY2025 annual figure was $442000.0, up 149.72% from the prior year.
Tax Provisions for Q1 2026 stood at $120000.0, down from $442000.0 in the prior quarter.
The five-year high for Tax Provisions was $442000.0 in Q4 2025, with the low at -$605000.0 in Q2 2023.
The 5-year median for Tax Provisions is $24000.0 (2022), against an average of -$23642.9.
The sharpest annual moves came in 2023 and 2025: Tax Provisions slumped 3658.82% in 2023, then soared 315.61% in 2025.
Zentalis Pharmaceuticals' Tax Provisions stood at -$360000.0 in 2022, then jumped by 62.5% to -$135000.0 in 2023, then tumbled by 51.85% to -$205000.0 in 2024, then jumped by 315.61% to $442000.0 in 2025, then plunged by 72.85% to $120000.0 in 2026.
Business Quant data shows ZNTL's Tax Provisions at $120000.0 in Q1 2026, $442000.0 in Q4 2025, and -$205000.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	59.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	75.45 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	267.73
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	13.31 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	1.90 Mn
10	Zentalis Pharmaceuticals	255.14 Mn	255.14 Mn	-	138,000.00

Download Data